What Should We Actually Assess?
Every person diagnosed with Alzheimer's has one thing in common.
The diagnosis.
Almost everything that follows is individual.
Every person diagnosed with Alzheimer's has the same disease.
No two people experience it in exactly the same way.
That is why diagnosis alone is never enough.
Identifying Alzheimer's is a medical event.
Living with Alzheimer's is a functional experience.
The diagnosis rarely changes.
Everyday life does.
Every conversation.
Every routine.
Every relationship.
Every decision.
Every safety concern.
Every support need.
Changes over time.
Yet those are often the very things that determine whether someone continues living well.
Once Alzheimer's has been diagnosed, the question is no longer simply:
What disease is present?
The question becomes:
How is this disease affecting this person's life?
Those are not the same question.
One identifies pathology.
The other determines care.
Earlier diagnosis has transformed Alzheimer's care.
Blood-based biomarkers are identifying disease sooner.
Disease-modifying therapies are creating opportunities to preserve function longer.
Research continues moving toward greater biological precision.
Those advances deserve celebration.
But they also create a new responsibility.
If we can identify Alzheimer's earlier than ever before...
What evidence should we actually be looking for afterward?
Not simply to document disease.
To understand life.
Meaningful assessment extends far beyond cognition alone.
It asks questions such as:
• Which abilities remain intact?
• Which abilities are beginning to change?
• Is judgment affecting safety?
• Can medications still be managed independently?
• Is driving still safe?
• Is communication becoming more difficult?
• Which routines continue supporting success?
• What environmental changes would increase independence?
• Which situations consistently create distress?
• Which strengths should be intentionally preserved?
Notice something.
Very few of those questions ask only what has been lost.
Instead, they seek to understand how the individual is functioning today.
Because Alzheimer's is not lived through biomarkers.
It is lived through conversations.
Relationships.
Daily routines.
Problem solving.
Decision making.
Successes.
Frustrations.
Adaptations.
Everyday life.
Those answers matter to everyone involved in care.
The physician evaluates disease.
The neurologist evaluates progression.
The researcher evaluates outcomes.
The administrator evaluates systems.
The caregiver experiences daily life.
The person living with Alzheimer's experiences all of it.
Each perspective contributes valuable information.
None, by itself, tells the complete story.
Assessment is not simply about identifying decline.
It is about identifying opportunity.
Every retained ability becomes something to preserve.
Every emerging challenge becomes an opportunity for proactive support.
Every successful strategy becomes something worth repeating.
Every environmental adaptation becomes another way to extend independence.
That is the difference between documenting Alzheimer's...
...and understanding the person living with it.
Perhaps the next evolution of Alzheimer's care is not simply diagnosing disease earlier.
Perhaps it is developing equally precise ways to understand everyday function.
Because what we assess shapes what we understand.
What we understand shapes what we plan.
And what we plan ultimately shapes outcomes.
Next in this series:
Assessment identifies support needs.
How do we translate assessment into an individualized plan for living with Alzheimer's?
Comments